INDIANA – Today, Governor Braun signed a Letter of Intent with Eli Lilly and Company to collaborate on a future pathway for ...

Eli Lilly, the maker of the popular GLP-1 injectable Mounjaro, has invested heavily in Houston as a biotechnology hub.

Eli Lilly’s late-stage study of the efficacy and safety of a treatment for type 2 diabetes has produced positive results.

Eli Lilly (LLY 1.85%) has accomplished something big over the past year. It's become the leading weight loss drug company in ...

Eli Lilly just released results of a clinical trial that may ease concerns about the safety of its new weight-loss pill ...

At the end of March, the elephant of the U.S. pharmaceutical sector announced a deal worth over $6 billion, and its stock ...

At the heart of the request is whether taking Foundayo - made with a new active ingredient called orforglipron - could be ...

Three years ago, Eli Lilly ( LLY 2.40%) and Novo Nordisk ( NVO +1.87%) had about the same market value. Given how well both ...

Even as Eli Lilly gets underway with its next major obesity launch in Foundayo, an FDA document related to the oral treatment ...

Eli Lilly (LLY) stock rises as Foundayo obesity pill shows 57% lower death risk and 16% reduction in heart attacks. FDA ...

A U.S. appeals court on Thursday revived a patent lawsuit that Teva Pharmaceutical brought against Eli ​Lilly over the companies' competing migraine drugs, after a judge ‌previously overturned a $176.

INDIANAPOLIS — Indiana Gov. Mike Braun is continuing his efforts for Indiana to be a part of conversations surrounding nuclear energy solutions. According to a news release from Braun’s office, Braun ...